|
| 产品描述 |
| Oclacitinib, also known as PF03394197, is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Oclacitinib inhibited JAK family members by 50% at concentrations (IC50 ’s) ranging from 10 to 99 nM and did not inhibit a panel of 38 non-JAK kinases (IC50 ’s > 1000 nm). Oclacitinib was most potent at inhibiting JAK1 (IC50 = 10 nm). Oclacitinib also inhibited the function of JAK1-dependent cytokines involved in allergy and inflammation (IL-2, IL-4, IL-6, and IL-13) as well as pruritus (IL-31) at IC50 ’s ranging from 36 to 249 nM. |
| 化学结构 |
 |
| 化学名称 |
| N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide |
| SMILES Code |
| O=S(C[C@H]1CC[C@H](N(C)C2=C3C(NC=C3)=NC=N2)CC1)(NC)=O |
| 基本信息 |
产品编号:XM035
产品名称:Oclacitinib
CAS#:1208319-26-9
分子式:C15H23N5O2S
精确分子量:337.15725
分子量:337.44
|
| 物化性质 |
外观: 类白色固体
纯度: >98%
运输信息: 非危险化学品，适于常温或冰袋运输。
储存条件: 低温，干燥，避光。
溶解性: 溶于DMSO, 不溶于水
储存期限: 3 年 -20℃ 固体储存 2 年 -80℃ 溶液储存 |
该产品只供科研使用，不能给病人提供。
|
|
|
